Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Shares of Quest Diagnostics Inc. (DGX) rose 3.78% to $186.77 on a day when the overall stock market declined, with the S&P 500 down 0.53%. This marks the third consecutive day of gains for Quest Diagnostics, although it remains 5.46% below its 52-week high of $197.55. The stock outperformed competitors like UnitedHealth Group, which rose 0.31%, while IQVIA Holdings fell 0.09% and Centene Corp. rose 0.90%. Trading volume was 1.5 million, surpassing the 50-day average of 1.0 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments